Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Myoglobin tames tumor growth and spread
Ulrich Flögel, Chi V. Dang
Ulrich Flögel, Chi V. Dang
Published March 23, 2009
Citation Information: J Clin Invest. 2009;119(4):766-768. https://doi.org/10.1172/JCI38796.
View: Text | PDF
Commentary

Myoglobin tames tumor growth and spread

  • Text
  • PDF
Abstract

Tumor growth is accompanied by tissue hypoxia, but does this reduced oxygen availability promote further tumor expansion, resulting in a vicious cycle? In this issue of the JCI, Galluzzo et al. report that increasing oxygen tension in tumor cells by ectopically expressing the oxygen-binding hemoprotein myoglobin indeed affects tumorigenesis (see the related article beginning on page 865). Tumors derived from cells transfected with myoglobin grew more slowly, were less hypoxic, and were less metastatic. These results will spur further mechanistic inquiry into the role of hypoxia in tumor expansion.

Authors

Ulrich Flögel, Chi V. Dang

×

Figure 1

Possible interactions of Mb within the cancer cell and the metabolic and functional consequences on tumor growth and spread.

Options: View larger image (or click on image) Download as PowerPoint
Possible interactions of Mb within the cancer cell and the metabolic and...
Tumor progression is well known to be associated with hypoxia, which itself gives rise to enhanced stabilization of the master regulator HIF-1α and also to an augmented release of ROS, caused by an increased leakage of the mitochondrial electron transport chain. Due to its high O2 affinity, Mb may serve as an O2 store and facilitate O2 transport from capillaries to mitochondria even under conditions of limited O2 availability. As a consequence, the ectopic expression of Mb within cancer cells carried out by Galluzzo et al. (4) leads to an improved O2 supply to the tumor, as reflected by the enhanced tissue O2 partial pressure (pO2) reported in this study. Additionally, Mb can reduce oxidative and nitrosative stress in cancer cells by detoxification of ROS to water and of NO radicals (NO•) to nitrate (NO3–), respectively. Together, these result in an environment of enhanced aerobic mitochondrial respiration and reduced levels of free radicals, favoring efficient degradation of HIF-1α, a key player in the progression of tumor metabolism to a more aggressive phenotype (15). As demonstrated by Galluzzo et al. (4), the metabolic environment created by the presence of Mb in cancer cells furthermore implicates cell differentiation, a reduction in vascular abnormalities, and a reduced selection of aggressive cells, which, in turn, retards tumor growth and metastatic spread.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts